Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/1998
03/05/1998WO1998008533A1 Sustained peptide-release formulation
03/05/1998WO1998008519A1 Chlorofluorocarbon-free mometasone furoate aerosol formulations
03/05/1998WO1998008517A2 Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
03/05/1998WO1998008491A1 Lock and key micelles
03/05/1998WO1998008490A1 Solid coprecipitates for enhanced bioavailability of lipophilic substances
03/05/1998WO1998008401A1 Use of bilayer forming emulsifiers in nutritional compositions comprising divalent metal salts
03/05/1998WO1998001160A3 Compositions suitable for delivery of genes to epithelial cells
03/05/1998WO1997044474A3 Viral particles which are masked or unmasked with respect to a cell receptor
03/05/1998WO1997037690A3 Cytomodulating conjugates of members of specific binding pairs
03/05/1998WO1997030731A3 Method of preparing polynucleotide-carrier complexes for delivery to cells
03/05/1998DE19634730A1 Bispecific antibodies, useful for imaging, diagnosis and treatment
03/05/1998CA2599944A1 P-selectin ligand proteins
03/05/1998CA2264131A1 Pharmaceutical composition containing osteogenesis-promoting substance
03/05/1998CA2263982A1 Lock and key micelles
03/04/1998EP0826375A2 Use of complex lipids as stabilizing additives for pharmaceutical preparations of digestive enzymes
03/04/1998EP0826371A1 External preparation containing emedastine
03/04/1998EP0826365A2 Tocopheryl ascorbyl phosphate-cyclodextrin clathrate and a topical dermal composition containing said clathrate
03/04/1998EP0826063A1 Single-vial formulations of dna/lipid complexes
03/04/1998EP0826051A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions
03/04/1998EP0825878A1 Composition and method for tumor imaging
03/04/1998EP0825877A1 Method and composition for prevention of posterior capsule opacification
03/04/1998EP0825876A1 Composition and method of enhancing electrotransport agent delivery
03/04/1998EP0825875A1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
03/04/1998EP0825865A1 Transdermal therapeutic system for administering testosterone
03/04/1998EP0825860A1 Composition comprising amoxycillin and clavulanic acid
03/04/1998EP0825858A1 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
03/04/1998EP0825854A1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
03/04/1998EP0825853A1 Prolonged nerve blockage by the combination of local anesthetics and glucocorticoids
03/04/1998EP0825849A1 Self-emulsifying formulations of lipophilic drugs
03/04/1998EP0825848A1 Novel collagen formulations
03/04/1998EP0794783A4 Cyclodextrins as suspending agents for pharmaceutical suspensions
03/04/1998EP0616523B1 Medicaments
03/04/1998EP0487632B1 Stabilized vaccine compositions
03/04/1998CN1175264A Novel cyclodextrin-derivatives and method for the preparation thereof
03/04/1998CN1175260A Induction of cytotoxic t -lymphocyte responses
03/04/1998CN1175208A Cross-linked microparticles and their use as therapeutic vehicles
03/04/1998CN1175206A Formulations and methods for reducing skin irritation
03/04/1998CN1174852A Structured copolymers used as absorbents, gels and carriers of metal ions
03/04/1998CN1174743A Application of composite fat used as stabilizing additive in medicine of digestive enzyme mixture
03/04/1998CN1174702A Agent for slow releasing medicine
03/03/1998US5723447 Acetate formation in nonaqeous solvent
03/03/1998US5723327 Hydrolyzes oligo- and polysaccharides with trehalose end unit; culturing sulfobus; foods, cosmetics, drugs
03/03/1998US5723151 Cellulose acetate phthalate enteric coating compositions
03/03/1998US5723148 Topical pharmaceutical compositions
03/03/1998US5723144 Ointment for wound treatment
03/03/1998US5723131 Contact lens containing a leachable absorbed material
03/03/1998US5723129 GnRH-leukotoxin chimeras
03/03/1998US5723126 Methods and compositions for therapeutic uses of a fibrin-specific monoclonal antibody
03/03/1998US5723114 Penetration enhancing compositions and methods of their use
03/03/1998CA2117351C Preparation of tablets of increased strength
02/1998
02/26/1998WO1998007864A1 Recombinant toxin fragments
02/26/1998WO1998007745A2 Compositions and methods for treating infections using analogues of indolicidin
02/26/1998WO1998007713A1 High molecular weight polymer-based prodrugs
02/26/1998WO1998007449A2 Polymer bile acid resorption inhibitors with simultaneous bile acid adsorbing effect
02/26/1998WO1998007446A1 Protein formulations
02/26/1998WO1998007441A1 Allogeneic histocompatibility complexes as mediators of cell destruction
02/26/1998WO1998007435A1 Eye treatments using synthetic thyroid hormone compositions
02/26/1998WO1998007434A1 Improvements in polymer compositions for chemotherapy and methods of treatment using the same
02/26/1998WO1998007429A2 Antifungal composition with enhanced bioavailability
02/26/1998WO1998007415A2 Methods for prevention of cellular proliferation and restenosis
02/26/1998WO1998007414A1 Compositions comprising microparticles of water-insoluble substances and method for preparing same
02/26/1998WO1998007409A1 Liposomes containing a cisplatin compound
02/26/1998WO1998007408A1 Novel liposome complexes for increased systemic delivery
02/26/1998WO1998007318A2 Method of making controlled release devices
02/26/1998WO1998000115A3 Stable drug form for oral administration and process for the preparation thereof
02/26/1998WO1998000114A3 Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
02/26/1998WO1997044063A3 Dha-pharmaceutical agent conjugates
02/26/1998WO1997041837A3 Microparticles
02/26/1998WO1997033622A3 Delivery of nucleic acids by porphyrins
02/26/1998DE19633268A1 Polymere Gallensäure-Resorptionsinhibitoren mit gleichzeitiger Gallensäure-Adsorberwirkung Polymeric bile acid Resorptionsinhibitoren with concomitant bile acid Adsorberwirkung
02/26/1998CA2263871A1 Allogeneic histocompatibility complexes as mediators of cell destruction
02/26/1998CA2263799A1 Compositions and methods for treating infections using analogues of indolicidin
02/26/1998CA2263754A1 Improvements in polymer compositions for chemotherapy and methods of treatment using the same
02/26/1998CA2263671A1 Polymer bile acid resorption inhibitors with simultaneous bile acid adsorbing effect
02/26/1998CA2213106A1 Tocopheryl ascorbyl phosphate-cyclodextrin clathrate and a topical dermal composition containing said clathrate
02/25/1998EP0825229A1 Polyurethane based thickening compositions and its use to thicken aqueous systems
02/25/1998EP0824916A1 Pranoprofen eyedrops containing organic amine
02/25/1998EP0824545A1 Peptide compositions with growth factor-like activity
02/25/1998EP0824453A1 Novel uses of heptafluoropropane
02/25/1998EP0824354A1 Methods to inhibit late radiation-induced skin damage
02/25/1998EP0824353A1 Methods to inhibit acute radiation-induced skin damage
02/25/1998EP0824352A1 Cyclodextrin compounds and methods of making and use thereof
02/25/1998CN1174512A Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
02/25/1998CN1174505A Pharmaceutical composition comprising lamotrigine
02/25/1998CN1174502A Solid active agent preparations containing hydroxypropyl cellulose
02/25/1998CN1174030A Triphenyl diamidine enteric coated tablet as vermifuge
02/24/1998US5721347 Esters and amides of substituted pyrrole acetic acids
02/24/1998US5721275 Slow release vehicles for minimizing skin irritancy of topical compositions
02/24/1998US5721229 Soluble forms of cephalosporins and treatment of animals
02/24/1998US5721122 Obtaining lymphocytes
02/24/1998US5721108 Capable of mediating antibody-dependent cellular cytotoxicity or complement-dependent cytolysis
02/24/1998US5720974 Compression molding mixture of active material, carbohydrate and water
02/24/1998US5720973 Dissolving active substance with phospholipid and water-soluble lipid, evaporating solution to form residue, stirring in acidic buffer, cooling, adjusting ph and sterilizing
02/24/1998US5720954 Treating patient having carcinoma overexpressing her2 receptor by administering cytotoxic factor and antibody binding to receptor, which sensitizes tumor cells to said factor
02/24/1998US5720950 Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use
02/24/1998US5720948 Non-ionic surfactant emulsion vehicles and their use for deposition of drug into and across skin
02/24/1998US5720937 In vivo tumor detection assay
02/24/1998CA2154103C Treatment of mucous membrane disease, trauma or condition and for the relief of pain
02/19/1998WO1998006848A1 GnRH-LEUKOTOXIN CHIMERAS
02/19/1998WO1998006442A1 Isotopic urea tablets
1 ... 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 ... 1712